• Title/Summary/Keyword: 93

Search Result 22,520, Processing Time 0.036 seconds

레미콘Q&A

  • 한국레미콘공업협회
    • 레미콘
    • /
    • no.4 s.67
    • /
    • pp.93-93
    • /
    • 2001

  • PDF

DMSO Improves Motor Function and Survival in the Transgenic SOD1-G93AMouse Model of Amyotrophic Lateral Sclerosis (DMSO 투여된 근위축성 측삭경화증 SOD1-G93A 형질 변환 마우스 모델에서의 근육 기능과 생존 기간 증가 효과)

  • Park, Kyung-Ho;Kim, Yeon-Gyeong;Park, Hyun Woo;Lee, Hee Young;Lee, Jeong Hoon;Patrick, Sweeney;Park, Larry Chong;Park, Jin-Kyu
    • Journal of Life Science
    • /
    • v.32 no.8
    • /
    • pp.611-621
    • /
    • 2022

  • Dimethyl sulfoxide (DMSO) is commonly used as control or vehicle solvent in preclinical research of neurodegenerative diseases such as amyotrophic lateral sclerosis (ALS) due to its ability to dissolve lipophilic compounds and cross the blood brain barrier. However, the biochemical effects of DMSO on the outcomes of preclinical research are often overlooked. In the present study, we investigated whether the long-term oral administration of 5% DMSO affects the neurological, functional, and histological disease phenotype of the copper/zinc superoxide dismutase glycine 93 to alanine mutation (SOD1-G93A) mouse model of amyotrophic lateral sclerosis. SOD1-G93A transgenic mice showed shortened survival time and reduced motor function. We found that administration with DMSO led to increased mean survival time, reduced neurological scores, and improved motor performance tested using the rotarod and grip strength tests. On the other hand, DMSO treatment did not attenuate motor neuron loss in the spinal cord and denervation of neuromuscular junctions in the skeletal muscle. These results suggest that DMSO administration could improve the quality of life of the SOD1-G93A mouse model of ALS without affecting motor neuron denervation. In conclusion, the use of DMSO as control or vehicle solvent in preclinical research may affect the behavioral outcomes in the SOD1-G93A mouse model. The effect of the vehicle should be thoroughly considered when interpreting therapeutic efficacy of candidate drugs in preclinical research.

  • https://doi.org/10.5352/JLS.2022.32.8.611 인용 PDF KSCI HTML

회원 동정

  • Korean Structural Engineers Association
    • 건축구조
    • /
    • v.12 no.4
    • /
    • pp.93-93
    • /
    • 2005

  • PDF